MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures

BMC Medical Genomics

Volumn 2, Issue , 2009, Pages

  Zangrando, Andrea ^a   Dell'Orto, Marta Campo ^a   Te Kronnie, Geertruy ^a   Basso, Giuseppe ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HOX PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; GENE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEISI GENE; NG2 GENE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UPREGULATION;

EID: 68349085602     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-2-36     Document Type: Article

References (56)

1. HOX genes: seductive science, mysterious mechanisms. TR Lappin DG Grier A Thompson HL Halliday, Ulster Med J 2006 75 1 23 31 16457401
2. MLL Gene rearrangement, Cytogenetic 11q23 Abnormalities, and Expression of the NG2 Molecule in Infant Acute Myeloid leukemia. JM Hilden FO Smith JL Frestedt R McGlennen WB Howells PH Sorensen DC Arthur WG Woods J Buckley ID Bernstein JH Kersey, Blood 1997 89 10 3801 3805 9160687
3. Molecular genetics in acute leukaemia. JD Rowley, Leukemia 2000 14 513 17 10.1038/sj.leu.2401600 10720153
4. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. A Daser TH Rabbitts, Semin Cancer Biol 2005 15 3 175 88 10.1016/j.semcancer.2005.01.007 15826832
5. The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumor tropism. EC Collins TH Rabbitts, Trends Mol Med 2002 8 9 436 442 10.1016/S1471-4914(02)02397-3 12223315 (Pubitemid 34975990)
6. Chromosomal translocations involving the MLL gene: molecular mechanisms. PD Aplan, DNA Repair (Amst) 2006 5 910 1265 72 Review 16797254 10.1016/j.dnarep.2006.05.034 (Pubitemid 44308465)
7. Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification. L De Zen S Bicciato G te Kronnie G Basso, Leukemia 2003 17 8 1557 65 10.1038/sj.leu.2403013 12886243 (Pubitemid 36986958)
8. Immunophenotype signature as a tool to define prognostic subgroups in childhood acute myeloid leukemia. A Zangrando A Luchini B Buldini R Rondelli A Pession S Bicciato G te Kronnie G Basso, Leukemia 2006 20 5 888 91 10.1038/sj.leu.2404175 16525493
9. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. SA Armstrong JE Staunton LB Silverman R Pieters ML den Boer MD Minden SE Sallan ES Lander TR Golub SJ Korsmeyer, Nat Genet 2002 30 1 41 7 10.1038/ng765 11731795 (Pubitemid 34886688)
10. New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes. A Kohlmann C Schoch M Dugas S Schnittger W Hiddemann W Kern T Haferlach, Leukemia 2005 19 6 953 64 10.1038/sj.leu.2403746 15815718 (Pubitemid 40862005)
11. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. T Flohr A Schrauder G Cazzaniga R Panzer-Grümayer V van der Velden S Fischer M Stanulla G Basso FK Niggli BW Schäfer R Sutton R Koehler M Zimmermann MG Valsecchi H Gadner G Masera M Schrappe JJ van Dongen A Biondi CR Bartram International BFM Study Group (I-BFM-SG), Leukemia 2008 22 4 771 82 10.1038/leu.2008.5 18239620 (Pubitemid 351552626)
12. Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols. A Pession R Rondelli G Basso C Rizzari AM Testi F Fagioli P De Stefano F Locatelli AML Strategy & Study Committee of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP), Leukemia 2005 19 12 2043 53 10.1038/sj.leu.2403869 16107897 (Pubitemid 41741596)
13. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. R Pieters M Schrappe P De Lorenzo I Hann G De Rossi M Felice L Hovi T LeBlanc T Szczepanski A Ferster G Janka J Rubnitz L Silverman J Stary M Campbell CK Li G Mann R Suppiah A Biondi A Vora MG Valsecchi, Lancet 2007 370 9583 240 50 10.1016/S0140-6736(07)61126-X 17658395 (Pubitemid 47082422)
14. Multiple Hypothesis Testing in Microarray Experiments. S Dudoit JP Shaffer JC Boldrick, U.C. Berkeley Division of Biostatistics Working Paper Series 2002 http://www.bepress.com/ucbbiostat/paper110
15. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4:11) abnormality. T Rozovskaia E Feinstein O Mor R Foa J Blechman T Nakamura CM Croce G Cimino E Canaani, Oncogene 2001 20 7 874 8 10.1038/sj.onc.1204174 11314021 (Pubitemid 32198181)
16. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. P Wong M Iwasaki TC Somervaille CW So ML Cleary, Genes Dev 2007 21 21 2762 74 17942707 10.1101/gad.1602107 (Pubitemid 350070722)
17. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. A Miyoshi Y Kitajima K Sumi K Sato A Hagiwara Y Koga K Miyazaki, Br J Cancer 2004 90 6 1265 73 10.1038/sj.bjc.6601685 15026811 (Pubitemid 38496823)
18. AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. HJ Lee JO Pyo Y Oh HJ Kim SH Hong YJ Jeon H Kim DH Cho HN Woo S Song JH Nam HJ Kim KS Kim YK Jung, Nat Cell Biol 2007 9 11 1303 10 10.1038/ncb1650 17952061 (Pubitemid 350042362)
19. Identification and sequence of human PKY, a putative kinase with increased expression in multidrug-resistant cells, with homology to yeast protein kinase Yak1. DA Begley MB Berkenpas KE Sampson I Abraham, Gene 1997 200 12 35 43 10.1016/S0378-1119(97)00350-8 9373137 (Pubitemid 27460469)
20. JNK Regulates HIPK3 Expression and Promotes Resistance to Fas-mediated Apoptosis in DU 145 Prostate Carcinoma Cells. JF Curtin TG Cotter, J Biol Chem 2004 279 17 17090 100 10.1074/jbc.M307629200 14766760 (Pubitemid 38560465)
21. HOXA9 is required for survival in human MLL-rearranged acute leukemias. J Faber AV Krivtsov MC Stubbs R Wright TN Davis M van den Heuvel-Eibrink Christian M Zwaan Andrew L Kung Scott A Armstrong, Blood 2009 113 11 2375 85 10.1182/blood-2007-09-113597 19056693
22. Spreading and focal contact formation of human melanoma cells in response to the stimulation of both melanoma-associated proteoglycan (NG2) and alpha 4 beta 1 integrin. J Iida AM Meijne RC Spiro E Roos LT Furcht JB McCarthy, Cancer Res 1995 55 10 2177 85 7743521
23. Validation of NG2 antigen in identifying BP-ALL patients with MLL rearrangements using qualitative and quantitative flow cytometry: a prospective study. A Zangrando F Intini G te Kronnie G Basso, Leukemia 2008 22 4 858 61 10.1038/sj.leu.2404952 17851550 (Pubitemid 351552637)
24. A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. A Barberis K Widenhorn L Vitelli M Busslinger, Genes Dev 1990 5 849 59 10.1101/gad.4.5.849 2116362
25. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. B Adams P Dörfler A Aguzzi Z Kozmik P Urbánek I Maurer-Fogy M Busslinger, Genes Dev 1992 6 9 1589 607 10.1101/gad.6.9.1589 1516825
26. Pre-B lymphocyte-specific transcriptional control of the mouse VpreB gene. T Okabe SR Bauer A Kudo, Eur J Immunol 1992 22 1 31 6 10.1002/eji. 1830220106 1730257
27. Transcription of the blk gene in human B lymphocytes is controlled by two promoters. YH Lin EJ Shin MJ Campbell JE Niederhuber, J Biol Chem 1995 270 43 25968 75 10.1074/jbc.270.43.25968 7592787
28. Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein. P Zwollo S Desiderio, J Biol Chem 1994 269 21 15310 7 8195169
29. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. D Fitzsimmons W Hodsdon W Wheat SM Maira B Wasylyk J Hagman, Genes Dev 1996 10 17 2198 211 10.1101/gad.10.17.2198 8804314
30. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Z Kozmik S Wang P Dörfler B Adams M Busslinger, Mol Cell Biol 1992 12 6 2662 72 1375324
31. Roles of EBF and Pax-5 in B lineage commitment and development. H Maier J Hagman, Semin Immunol 2002 14 6 415 22 10.1016/S1044532302000763 12457614
32. Regulation of mouse CD72 gene expression during B lymphocyte development. H Ying JI Healy CC Goodnow JR Parnes, J Immunol 1998 161 9 4760 7 9794407
33. Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. M Schebesta PL Pfeffer M Busslinger, Immunity 2002 17 4 473 85 10.1016/S1074-7613(02)00418-1 12387741 (Pubitemid 35223536)
34. BLNK is associated with the CD72/SHP-1/Grb2 complex in the WEHI231 cell line after membrane IgM cross-linking. N Fusaki S Tomita Y Wu N Okamoto R Goitsuka D Kitamura N Hozumi, Eur J Immunol 2000 30 5 1326 30 10.1002/(SICI)1521-4141(200005)30:5<1326::AID-IMMU13263.0.CO;2-Q 10820378
35. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. SL Nutt AM Morrison P Dörfler A Rolink M Busslinger, EMBO J 1998 17 8 2319 33 9545244 10.1093/emboj/17.8.2319 (Pubitemid 28171916)
36. CD72-mediated suppression of human naive B cell differentiation by down-regulating X-box binding protein 1. T Yamazaki H Nagumo T Hayashi K Sugane K Agematsu, Eur J Imm 2005 35 8 2325 34 10.1002/eji.200425639 (Pubitemid 41179753)
37. Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex. RH Carter GM Doody JB Bolen DT Fearon, J Immunol 1997 158 7 3062 9 9120258
38. An essential role for BLNK in human B cell development. Y Minegishi J Rohrer E Coustan-Smith HM Lederman R Pappu D Campana AC Chan ME Conley, Science 1999 286 5446 1954 7 10.1126/science.286.5446.1954 10583958
39. The direct recruitment of BLNK to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways. S Kabak BJ Skaggs MR Gold M Affolter KL West MS Foster K Siemasko AC Chan R Aebersold MR Clark, Mol Cell Biol 2002 22 8 2524 35 11909947 10.1128/MCB.22.8.2524-2535.2002 (Pubitemid 34262975)
40. Expression of the adaptor protein BLNK/SLP-65 in childhood acute lymphoblastic leukemia. C Imai ME Ross G Reid E Coustan-Smith KR Schultz CH Pui JR Downing D Campana, Leukemia 2004 18 5 922 5 10.1038/sj.leu.2403349 15029213 (Pubitemid 38714615)
41. Genetic networks that regulate B lymphopoiesis. KL Medina H Singh, Curr Opin Hematol 2005 12 3 203 9 10.1097/01.moh.0000160735.67596.a0 15867576 (Pubitemid 40676827)
42. LIM domain proteins in leukaemia and development. I Sánchez- García TH Rabbitts, Semin Cancer Biol 1993 4 6 349 58 8142620
43. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. ME Ross X Zhou G Song SA Shurtleff K Girtman WK Williams HC Liu R Mahfouz SC Raimondi N Lenny A Patel JR Downing, Blood 2003 102 8 2951 9 10.1182/blood-2003-01-0338 12730115 (Pubitemid 37248870)
44. The TCL1 family of oncoproteins: co-activators of transformation. MA Teitell, Nat Rev Cancer 2005 5 9 750 10.1038/nrc1711 (Pubitemid 41486368)
45. Mechanisms of B-cell lymphoma pathogenesis. R Küppers, Nat Rev Cancer 2005 5 4 251 62 10.1038/nrc1589 15803153 (Pubitemid 40488631)
46. TCL1A expression delineates biological and clinical variability in B-cell lymphoma. M Aggarwal R Villuendas G Gomez SM Rodriguez-Pinilla M Sanchez-Beato D Alvarez N Martinez A Rodriguez ME Castillo FI Camacho S Montes-Moreno JA Garcia-Marco E Kimby DG Pisano M Piris, Mod Pathol 2009 22 206 215 10.1038/modpathol.2008.148 18820675
47. Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia. L Grubach C Juhl-Christensen A Rethmeier LH Olesen A Aggerholm P Hokland M Ostergaard, Eur J Haematol 2008 81 2 112 22 10.1111/j.1600-0609.2008.01083.x 18410541 (Pubitemid 352022720)
48. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. E Tiacci S Pileri A Orleth R Pacini A Tabarrini F Frenguelli A Liso D Diverio F Lo-Coco B Falini, Cancer Res 2004 64 20 7399 404 10.1158/0008-5472.CAN-04-1865 15492262 (Pubitemid 39372080)
49. New insight into the molecular mechanisms of MLL-associated leukemia. ZY Li DP Liu CC Liang, Leukemia 2005 19 2 183 90 10.1038/sj.leu.2403602 15618964 (Pubitemid 40220578)
50. Transcriptional control of early B cell development. M Busslinger, Annu Rev Immunol 2004 22 55 79 10.1146/annurev.immunol.22.012703.104807 15032574 (Pubitemid 38680418)
51. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. CG Mullighan S Goorha I Radtke CB Miller E Coustan-Smith JD Dalton K Girtman S Mathew J Ma SB Pounds X Su CH Pui MV Relling WE Evans SA Shurtleff JR Downing, Nature 2007 446 7137 758 64 10.1038/nature05690 17344859 (Pubitemid 46582031)
52. Context-dependent Pax-5 repression of a PU.1/NF-kappaB regulated reporter gene in B lineage cells. Y Linderson NS French MF Neurath S Pettersson, Gene 2001 262 12 107 14 10.1016/S0378-1119(00)00546-1 11179673 (Pubitemid 32155340)
53. The LIM domain: regulation by association. I Bach, Mec Dev 2000 91 5 17 10.1016/S0925-4773(99)00314-7 (Pubitemid 30125900)
54. The LIM domain protein Lmo2 binds to AF6, a translocation partner of the MLL oncogene. V Bégay-Müller S Ansieau A Leutz, FEBS Lett 2002 521 13 36 8 10.1016/S0014-5793(02)02814-4 12067721 (Pubitemid 34628453)
55. C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line. JD Bretz SC Williams M Baer PF Johnson RC Schwartz, Proc Natl Acad Sci USA 1994 91 15 7306 10 8041785 10.1073/pnas.91.15.7306 (Pubitemid 24226852)
56. Expression of interleukin-6 receptors by pediatric acute lymphoblastic leukemia cells with the t(4;11) translocation: a possible target for therapy with recombinant IL6-Pseudomonas exotoxin. L Gu M Zhou I Jurickova AM Yeager RJ Kreitman CN Phillips HW Findley, Leukemia 1997 11 10 1779 86 10.1038/sj.leu.2400757 9324301